
The Siro Drug Eluting Stent combines the U.S. patented Direct-Stent® design, the proven success of Sirolimus drug to reduce tissue ingrowth and proliferation, leading to reduced restenosis.





Quality-Focused Engineering
| Specification | Description |
|---|---|
| Stent Design | Hybrid Design — Open and Closed Cell |
| Stent Material | L605 Cobalt Chromium Alloy |
| Wall Thickness | 0.08 mm / 0.003 in |
| Strut Width | 0.07 mm |
| Balloon System | Rx Rapid Exchange Balloon Catheter |
| Balloon Material | Low Compliant — Nylon Blend |
| Nominal Pressure** | 10 ATM |
| Rated Burst Pressure | 16 ATM |
| Minimum Guiding Catheter* | 5F (2.0–4.0 mm diameter); 6F (4.5–5.0 mm diameter) |
| Drug | Sirolimus Analogue |
| Dose | 2.0 μg/mm² |
| Polymer | Biodegradable Stable Polymer |
| Crimped Profile | 0.9–1.25 mm |
| Tip Entry Profile | 0.017 in |
| Delivery Catheter Length | Approximately 142 cm |
* See individual manufacturer for guide catheter Fr equivalent.
** Assure full deployment of stent. Deployment pressures should be based on lesion characteristics.
| Stent Diameter (mm) | Stent Length (mm) |
|---|---|
| 2.25 | 08, 13, 18, 23, 28, 33, 38 |
| 2.5 | 08, 13, 18, 23, 28, 33, 38, 43, 48 |
| 2.75 | 08, 13, 18, 23, 28, 33, 38, 43, 48 |
| 3.0 | 08, 13, 18, 23, 28, 33, 38, 43, 48 |
| 3.5 | 08, 13, 18, 23, 28, 33, 38, 43, 48 |
| 4.0 | 08, 13, 18, 23, 28, 33, 38 |
| 4.5** | 13, 18, 23, 28 |
| 5.0** | 13, 18, 23, 28 — Custom order |
*See individual manufacturer for Guide Catheter Fr equivalent
**Assure full deployment of stent. Deployment pressures should be based on lesion characteristics.